ARCHIVES

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

DRCCA Board Okays Concepts Of New Cooperative Agreements For Smoking Program, Flow Cytometry For Bladder Cancer

October 28, 1983

Letter to the Editor: Gensia Official Says No “Threat” Implied In Question Study

May 26, 1995

RFPs Available, NIH Funding Strategies

February 18, 1994

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000

NCI contract Awards; RFPs Available; RFAs, PA Available.

October 14, 1994

NCI SBIR Offers $10 million in 10 Awards

February 18, 2011